company background image
PGNY logo

Progyny NasdaqGS:PGNY Stock Report

Last Price

US$14.74

Market Cap

US$1.3b

7D

-6.4%

1Y

-60.1%

Updated

17 Dec, 2024

Data

Company Financials +

Progyny, Inc.

NasdaqGS:PGNY Stock Report

Market Cap: US$1.3b

PGNY Stock Overview

A benefits management company, specializes in fertility and family building benefits solutions in the United States. More details

PGNY fundamental analysis
Snowflake Score
Valuation6/6
Future Growth2/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 82.9% below our estimate of its fair value

Earnings are forecast to grow 19.59% per year

Earnings have grown 26.9% per year over the past 5 years

Trading at good value compared to peers and industry

Analysts in good agreement that stock price will rise by 27.9%

Risk Analysis

Volatile share price over the past 3 months compared to the US market


My Notes

Capture your thoughts, links and company narrative

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
Analyst Price Target
Consensus Narrative from 7 Analysts

New Maternity Services And Health Plan Partnerships Will Expand Future Opportunities

Key Takeaways Strong demand for new services and strategic partnerships with health plans are set to enhance market reach and drive revenue growth. High client acquisition, stable utilization rates, and a strong renewal rate indicate robust growth potential and customer satisfaction.
View narrative
US$18.86
FV
21.8% undervalued intrinsic discount
7.47%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
6 days ago author updated this narrative

Progyny, Inc. Competitors

HealthEquity

NasdaqGS:HQY

US$8.1b

Molina Healthcare

NYSE:MOH

US$16.9b

Humana

NYSE:HUM

US$31.4b

Centene

NYSE:CNC

US$29.9b

Price History & Performance

Summary of share price highs, lows and changes for Progyny
Historical stock prices
Current Share PriceUS$14.74
52 Week HighUS$42.08
52 Week LowUS$13.39
Beta1.35
1 Month Change7.04%
3 Month Change-39.69%
1 Year Change-60.14%
3 Year Change-70.61%
5 Year Change-42.53%
Change since IPO-7.53%

Recent News & Updates

Progyny: Rating Downgrade On Uncertain Growth Outlook

Nov 26

Progyny's (NASDAQ:PGNY) Solid Earnings Have Been Accounted For Conservatively

Nov 21
Progyny's (NASDAQ:PGNY) Solid Earnings Have Been Accounted For Conservatively

Progyny: After A Terrible Year, I'm Out (Rating Downgrade)

Nov 18

Recent updates

Progyny: Rating Downgrade On Uncertain Growth Outlook

Nov 26

Progyny's (NASDAQ:PGNY) Solid Earnings Have Been Accounted For Conservatively

Nov 21
Progyny's (NASDAQ:PGNY) Solid Earnings Have Been Accounted For Conservatively

Progyny: After A Terrible Year, I'm Out (Rating Downgrade)

Nov 18

Here's What's Concerning About Progyny's (NASDAQ:PGNY) Returns On Capital

Oct 21
Here's What's Concerning About Progyny's (NASDAQ:PGNY) Returns On Capital

Progyny: Poor Year Raises Concerns For Future (Downgrade)

Oct 15

Progyny, Inc.'s (NASDAQ:PGNY) Stock Retreats 28% But Earnings Haven't Escaped The Attention Of Investors

Sep 29
Progyny, Inc.'s (NASDAQ:PGNY) Stock Retreats 28% But Earnings Haven't Escaped The Attention Of Investors

Progyny: Downgrading As Uncertainties Increase

Aug 15

Progyny, Inc. (NASDAQ:PGNY) Stocks Pounded By 25% But Not Lagging Market On Growth Or Pricing

Aug 11
Progyny, Inc. (NASDAQ:PGNY) Stocks Pounded By 25% But Not Lagging Market On Growth Or Pricing

At US$27.79, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely?

Jul 20
At US$27.79, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely?

Progyny: Recent Stock Decline Provides Buying Opportunity

Jul 12

Progyny's (NASDAQ:PGNY) Returns Have Hit A Wall

Jun 23
Progyny's (NASDAQ:PGNY) Returns Have Hit A Wall

Progyny: At This Price, Secular Tailwinds Are Too Compelling To Ignore

Jun 10

Progyny: No Change To Long-Term Outlook

Jun 04

Why We're Not Concerned About Progyny, Inc.'s (NASDAQ:PGNY) Share Price

Apr 29
Why We're Not Concerned About Progyny, Inc.'s (NASDAQ:PGNY) Share Price

Is Now An Opportune Moment To Examine Progyny, Inc. (NASDAQ:PGNY)?

Apr 03
Is Now An Opportune Moment To Examine Progyny, Inc. (NASDAQ:PGNY)?

Progyny: Long-Term Outlook Remains Positive, Reiterate Buy

Mar 15

Progyny: Long-Term Thesis Still Intact

Mar 09

Progyny's (NASDAQ:PGNY) Returns On Capital Are Heading Higher

Mar 01
Progyny's (NASDAQ:PGNY) Returns On Capital Are Heading Higher

Progyny, Inc.'s (NASDAQ:PGNY) P/E Still Appears To Be Reasonable

Jan 07
Progyny, Inc.'s (NASDAQ:PGNY) P/E Still Appears To Be Reasonable

Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Dec 11
Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)

Nov 08
Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)

Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Aug 24
Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

There's Been No Shortage Of Growth Recently For Progyny's (NASDAQ:PGNY) Returns On Capital

Aug 06
There's Been No Shortage Of Growth Recently For Progyny's (NASDAQ:PGNY) Returns On Capital

Progyny (NASDAQ:PGNY) Is Looking To Continue Growing Its Returns On Capital

May 06
Progyny (NASDAQ:PGNY) Is Looking To Continue Growing Its Returns On Capital

When Should You Buy Progyny, Inc. (NASDAQ:PGNY)?

Jan 25
When Should You Buy Progyny, Inc. (NASDAQ:PGNY)?

Progyny (NASDAQ:PGNY) Shareholders Will Want The ROCE Trajectory To Continue

Dec 12
Progyny (NASDAQ:PGNY) Shareholders Will Want The ROCE Trajectory To Continue

Shareholder Returns

PGNYUS HealthcareUS Market
7D-6.4%-10.8%0.1%
1Y-60.1%-11.9%26.1%

Return vs Industry: PGNY underperformed the US Healthcare industry which returned -9.2% over the past year.

Return vs Market: PGNY underperformed the US Market which returned 27.3% over the past year.

Price Volatility

Is PGNY's price volatile compared to industry and market?
PGNY volatility
PGNY Average Weekly Movement11.8%
Healthcare Industry Average Movement7.5%
Market Average Movement6.3%
10% most volatile stocks in US Market16.7%
10% least volatile stocks in US Market3.1%

Stable Share Price: PGNY's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: PGNY's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2008565Pete Anevskiwww.progyny.com

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment.

Progyny, Inc. Fundamentals Summary

How do Progyny's earnings and revenue compare to its market cap?
PGNY fundamental statistics
Market capUS$1.27b
Earnings (TTM)US$57.27m
Revenue (TTM)US$1.14b

21.9x

P/E Ratio

1.1x

P/S Ratio

Is PGNY overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PGNY income statement (TTM)
RevenueUS$1.14b
Cost of RevenueUS$891.91m
Gross ProfitUS$246.83m
Other ExpensesUS$189.55m
EarningsUS$57.27m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.67
Gross Margin21.68%
Net Profit Margin5.03%
Debt/Equity Ratio0%

How did PGNY perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/17 07:19
End of Day Share Price 2024/12/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Progyny, Inc. is covered by 20 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhilin LongBerenberg
Nisala WeerasuriyaBerenberg
Allen LutzBofA Global Research